Barriers to communication

Slides:



Advertisements
Similar presentations
The FREEDOM Study (Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances) Source Jaber BL, Schiller B, Burkart JM, et al.
Advertisements

A 1 FDA Advisory Committee for Zelnorm Jeffrey D. Roberts, B.Sc. President & Founder Irritable Bowel Syndrome Self Help Group, Irritable Bowel Syndrome.
May 25, 2005 Somatoform Disorder or Medically Unexplained Symptoms Bruce Slater, MD, MPH Associate Professor (CHS) University of Wisconsin School of Medicine.
Overview of Irritable Bowel Syndrome
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Men, Women and Ageing Gender differences in the impact of gastrointestinal problems and their association with frailty Derrick Lopez 1, Leon Flicker 1.
Prescribing information is available at this meeting 1 MODULE 2 IDENTIFICATION, SCREENING AND DIAGNOSIS DET 808.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
CM-1 Chronic Constipation: An Unresolved Problem for Many Patients Charlene Prather, MD Division of Gastroenterology and Hepatology Saint Louis University.
1 Psychosocial Issues Faced by PLHIV HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Causes of Constipation. Main Point Constipation is a SYMPTOM Constipation is not a diagnosis.
Assessment and management of bowel problems in residential care Mary-Anne Harris Clinical Specialty Nurse Continence 1.
Prim. mag. Marija Cesar Komar dr.med. 1st Congress of the Slovenian Association for Pain Therapy and Symposium on Clinical Neurophysiology of Pain Bled,
IN 1 NDA Gastrointestinal Advisory Committee Meeting Gaithersburg, Maryland June 26, 2000 Gastrointestinal Advisory Committee Meeting Gaithersburg,
ASSOCIATION BETWEEN ABDOMINAL COMPLAINTS AND NARCOTIC USE AMONG PATIENTS WITH SHORT BOWEL SYNDROME RECEIVING TEDUGLUTIDE Ken Fujioka, 1 Khursheed Jeejeebhoy,
Conclusions Sidney Cohen, MD Chairman, Department of Medicine Temple University School of Medicine Philadelphia, Pennsylvania Sidney Cohen, MD Chairman,
Are patients with chronic diseases a new challenge to general practice? Patients with irritable bowel syndrome in general practice Patients with irritable.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation Michael Camilleri, M.D., Rene Kerstens, M.Sc., An Rykx, Ph.D., and Lieve Vandeplassche,
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
T Relationships do matter: Understanding how nurse-physician relationships can impact patient care outcomes Sandra L. Siedlecki PhD RN CNS.
The pharmacist’s role: The rational use of topical steroids
A Clinical Overview.
Dissociative Amnesia.
Concordance Of Clinical & Electronic Data In Assessment of Depression: Findings From The Smartphone And Online Usage Based Evaluation For Depression (SOLVD)
Validated Distress Screening Tools Brief Symptom Inventory (BSI-18)
Multimodal Management of Opioid-Induced Constipation
Opioids for the management chronic non-cancer pain in Primary Care:
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
New NC Medical Board Opioid Prescribing CME Requirements
PECULLIARITIES OF CHRONIC PAIN ASSESSMENT AND MANAGEMENT
Quality of Life Assessment
IRRITABLE BOWEL SYNDROME
Project Visionary Pitch MyGIPAL
Minoru Miyazato, Asuka Ashikari, Takuma Oshiro, and Seiichi Saito
Unveil the importance of pain management in cancer patients
The Relationship Between Mental and Physical Health
Clinical Correlates of Mental Health Issues in Outpatients with Inflammatory Bowel Disease under Routine Care Taryn Lores Health Psychologist, IBD Service.
Eric Shah, William D. Chey, Chris Almario, Brennan Spiegel
Barriers to communication
OIC and opioid adherence
mHealth for Chronic Disease:
Link Between Hearing Loss and Depression This is a very interesting discussion, because everyone want to know “how are hearing loss and depression linked?”
Antineoplastic Medications
Treatment of Clients Experiencing Pain Disorders
Opioids and the gut Job bag number: NP-EU-NAL-0059
Drugs for the treatment of irritable bowel syndrome (IBS)
Treatment of Clients Experiencing Pain Disorders
IRRITABLE BOWEL SYNDROME
Charles D. Gerson, Mary-Joan Gerson 
A Frontline Clinician's Guide to Managing Opioid-Induced Constipation
Michael Camilleri, Anthony Lembo, David A. Katzka 
Clinical Presentation
Writing Cochrane Protocol Cochrane Thailand Workshop 2017
Background 30% of acute hospital days used by patients in the last year of life 75% of people will be admitted to hospital in the last year of life Location.
Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations  Job F.M. van Boven, PharmD, PhD,
Clinical tips and pearls
BE MORE INVOLVED IN YOUR HEALTH CARE
Essentials of Good Pain Care: A Team-Based Approach
Opioid prescribing workflow in the electronic medical record.
Opioids and the gut Job bag number: NP-EU-NAL-0059
OIC and opioid adherence
Perspectives in Palliative Care
Development of Patient Defined Migraine Assessment
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Krista Stillson, BS | School of Nursing | DePaul University Objective
Medication Assisted Treatment of Opioid Use Disorder
Functional abdominal pain syndrome
Chronic opioid registry health maintenance tool.
Presentation transcript:

Barriers to communication Job bag number: NP-EU-NAL-0057 Date of preparation: September 2017 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.

OIC is the most common and bothersome adverse event affecting patients on long-term opioid treatment1 OIC is characterised by infrequent bowel movements and incomplete bowel evacuation, along with other GI symptoms including abdominal pain and bloating, straining and gastric reflux2 GI, gastrointestinal; OIC, opioid-induced constipation. *Experienced by ≥30% of patients.1 1. Bell TJ, et al. Pain Med 2009;10:35–42; 2. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-1261. 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.

As a result of their OIC symptoms, patients also experience a significant psychosocial impact on their lives Patients have been reported to experience embarrassment, depression, low self-esteem, social isolation, anger and frustration.1–3 “I am on and off the toilet straining to go…I look pregnant all the time, so I am self- conscious all of the time.”6 Some patients would rather not take opioids and endure their original pain, than experience the distressing pain of OIC.3–5 “I am always conscious of not overdoing the pain meds… I always think about the constipation that might result, and so I will try to take the smallest dose possible or do without.”5 OIC, opioid-induced constipation. 1. Rauck RL Pain Pract 2017;17:329–35 2. Larkin PJ, et al. Palliat Med 2008;22:796–807 3. Panchal SJ, et al. Int J Clin Pract 2007;61:1181–7 4. Morlion B, et al. Clin Drug Investig 2015;35:1–11 5. Dhingra L, et al. Pal Med 2012;27:447–56 6. Epstein RS et al. Adv Ther 2017;34:726–31 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.

Patients may struggle to communicate their symptoms due to their feelings towards OIC In an online survey of opioid-treated chronic pain patients (n=489), 70% were ashamed or embarrassed to talk to their HCP about OIC.1 Feelings of embarrassment, depression and social isolation are linked to the high prevalence of frustration and/or irritability experienced by patients.1 Some patients would rather suffer in silence than risk having to change or reduce their pain medication.2 HCP, healthcare provider; OIC, opioid-induced constipation. 1. Rauck RL, Pain Pract 2017;17:329–35 2. LoCasale RJ, et al. J Manag Care Spec Pharm 2016;22:236–45 Patients were asked “Do you have any of the following feelings due to OIC?” and chose all of their feelings that applied 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.

Patients not discussing their symptoms can lead to a disconnect between patient experience and physician perception1,2 Physicians may not fully appreciate the:1 extent of OIC symptoms negative effects on pain management and quality of life limited effectiveness of laxatives Effective communication between patients and their physicians, while essential for optimal patient outcomes can be hindered by time constraints and a reluctance to discuss embarrassing topics1–4 OIC, opioid-induced constipation. 1. LoCasale RJ, et al. J Manag Care Spec Pharm 2016;22:236–45 2. Rauck RL, Pain Pract 2017;17:329–35 3. Camilleri M, et al. Neurogastroenterol Motil 2014;26:1386–95; 4. Nelson AD, Camilleri M. Ther Adv Chronic Dis. 2016 Mar;7:121–34 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.

There are clinically available tools and assessments to help the diagnosis of OIC and facilitate conversations with patients1–4* Bristol stool form scale (BSFS): A visual aid designed to help determine stool frequency and categorise stools into seven categories3 Bowel function index (BFI) A patient-reported outcome tool that has a numerical scale measuring the mean of: (1) ease of defaecation, (2) feeling of incomplete bowel evacuation and (3) personal judgement of constipation1 Patient assessment of constipation quality of life (PACQL) A 12-item questionnaire which measures patients’ health-related quality of life in relation to their OIC and their response to OIC treatment4 Using brief, easy-to- administer questionnaires can help assess patients’ pain severity and other symptoms, including OIC1,2 In addition, patients may find it less embarrassing to write down symptoms, allowing them to be more specific on the impact of OIC on their daily lives3 1 2 3 OIC, opioid-induced constipation. *For use in both clinical trials and general clinical practice. 1. Nelson AD, Camilleri M. Ther Adv Chronic Dis. 2016 Mar;7:121–34 2. Gaertner, J et al. J Clin Gastroenterol 2015;49:9–16 3. Lewis SJ, Heaton KW. Scand J Gastroenterol 1997;32:920–24 4. Frank L et l. Scand J Gastroentrol 1999;34:870–7. 05/09/17 © Shionogi Limited. 33 Kingsway. London WC2B 6UF, UK Registered in England and Wales No. 07945432.